Bispecific monoclonal antibody therapy (anti HER-2/neu × anti CD 64) for human breast cancers that overexpress HER-2/neu
Keyword(s):
2010 ◽
Vol 10
(5)
◽
pp. 361-368
◽
2002 ◽
Vol 29
(4)
◽
pp. 365-366
◽